David is currently Senior Vice president in Eisai, responsible for Global Regulatory, Government Relations, Public Affairs and Product Safety. After qualifying in medicine, he practised as a physician and cardiologist, with additional interests in metabolic medicine and clinical toxicology. He spent 21 years as a senior regulatory in the UK and Europe. He was executive director of licensing in MCA, CPMP member, chairman of the MRFG and PER committees. He was CEO and Director of the UK Medical Devices Agency and on the creation of the MHRA acting joint chief executive. He worked on secondment at the EMEA /EMA on benefit risk methodologies.
Since 2005 he has worked for Eisai, currently he is also chairman of the ABPI regulatory committee and a member of the Innovation Board .Within EFPIA he chairs the Regulatory Committee and sits on the International Regulatory Board.
Chairman of the IFPMA Regulatory Science Committee, a member of the IFPMA Council and of the ICH Committee and General Assembly.
He is a past chairman of the CMR Advisory Board and currently sits as a member of the CIRS Scientific Advisory Council.